MUC16 and female reproductive organ cancer: According to the Gynecologic Cancer Inter-group criteria, during serial CA-125 measurements, disease progression is suspected when CA-125 concentration doubles the upper limit of the reference range in two occasions separated by at least 1 week (11, 12).